Download PDF
Semin Reprod Med 2003; 21(1): 005-008
DOI: 10.1055/s-2003-39989
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Guides to an Efficient Search for the Best Evidence

James H. Liu
  • Department of Obstetrics and Gynecology, University Hospitals of Cleveland, and Department of Reproductive Biology, Case Western Reserve University, Cleveland, Ohio
Further Information

Publication History

Publication Date:
12 June 2003 (online)

    Permissions and Reprints

ABSTRACT

As a clinician, the selection of the best treatment options for a patient given her clinical diagnosis can be challenging. Textbooks and the knowledge base acquired during residency and fellowship training may be out of date. The following article outlines how to perform a literature search to survey the available treatment options and ultimately how to look for evidence-based guidelines for management of the clinical problem.

KEYWORDS

Literature search - evidence-based guidelines - medical search engines

REFERENCES

  • 1 Ferenczy A, Mutter G. Endometrial hyperplasia and neoplasia: definition, diagnosis and management principles. In: Sciarra J, ed. Gynecology and Obstetrics [CD-ROM] Philadelphia: JB Lippincott 2000
    Search in Google Scholar
  • 2 Ferenczy A, Gelfand M M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia.  Am J Obstet Gynecol . 1989;  160 126-131
    PubMedSearch in Google Scholar
  • 3 Kurman R J, Kaminski P F, Norris H J. The behavior of endometrial hyperplasia.  Cancer . 1985;  56 403-412
    CrossrefPubMedSearch in Google Scholar
  • 4 Kurman R J, Kaminski P F, Norris H J. The behavior of endometrial hyperplasia: a long-term study of “untreated” hyperplasia in 170 patients.  Cancer . 1985;  56 403-412
    CrossrefPubMedSearch in Google Scholar
  • 5 Dunton C, Baak J, Palazzo J, van Diest P, McHugh M, Widra E. Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer.  Am J Obstet Gynecol . 1996;  174 1518-1521
    PubMedSearch in Google Scholar
  • 6 Wentz W B. Effect of a progestational agent on endometrial hyperplasia and endometrial cancer.  Obstet Gynecol . 1964;  24 370-375
    PubMedSearch in Google Scholar
  • 7 Moyer D L, de Lignieres B, Driguez P, Pez J-P. Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes.  Fertil Steril . 1993;  59 992-997
    PubMedSearch in Google Scholar
  • 8 Hickey M, Higham J, Fraser I S. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation (Cochrane Review). In: The Cochrane Library, Issue 3 Oxford: Update Software 2001
    Search in Google Scholar
  • 9 Fraser I S. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens.  Aust N Z J Obstet Gynaecol . 1990;  30 353-356
    CrossrefPubMedSearch in Google Scholar
  • 10 Saarikoski S, Yliskoski M, Penttila I. Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders.  Maturitas . 1990;  12 89-97
    CrossrefPubMedSearch in Google Scholar
  • 11 Perez-Medina T, Bajo J, Folgueira G, Haya J, Ortega P. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.  Gynecol Oncol. 1999;  73 299-304
    CrossrefPubMedSearch in Google Scholar